Medicine & Life Sciences
Ticagrelor
100%
Blood Platelets
80%
Clopidogrel
54%
Acute Coronary Syndrome
47%
Thrombosis
39%
Platelet Aggregation Inhibitors
32%
Percutaneous Coronary Intervention
32%
Aspirin
29%
Atherosclerotic Plaques
28%
Single-Domain Antibodies
27%
fostamatinib
23%
Glycoproteins
22%
Platelet Activation
21%
Platelet Aggregation
21%
Prasugrel Hydrochloride
20%
PCI 32765
18%
platelet membrane glycoprotein VI
18%
Atrial Fibrillation
17%
Adenosine
17%
Hemorrhage
17%
C-Type Lectins
16%
Inflammation
14%
P-Selectin
13%
Collagen
12%
Myocardial Infarction
12%
acalabrutinib
12%
cangrelor
11%
Therapeutics
10%
Hemostasis
10%
ST Elevation Myocardial Infarction
10%
Risk Assessment
10%
Syk Kinase
10%
Coronary Artery Disease
9%
Purinergic P2Y Receptor Antagonists
9%
(1,2-diamino-4-nitrobenzene)dichloroplatinum(II)
9%
TYK2 Kinase
9%
Fibrin
9%
Proton Pumps
8%
Neutrophils
8%
Monocytes
8%
Integrins
7%
Endotoxemia
7%
Idiopathic Thrombocytopenic Purpura
7%
Dimerization
7%
Atrial Natriuretic Factor
6%
Chemotaxis
6%
Salmonella
6%
Stents
6%
Phagocytosis
6%
Leukocytes
6%